Previous 10 | Next 10 |
Biotricitys New Digital Presence Reflects Commitment to Innovation in the Healthcare Space. REDWOOD CITY, CA / ACCESSWIRE / September 13, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology company, announc...
2023-08-30 11:46:27 ET More on Biotricity Biotricity ( BTCY ) Q1 2024 Earnings Call Transcript Biotricity touches $12M in annualized revenue Biotricity stock rises on surpassing $10M in annual revenue run rate Biotricity to launch commercial sales of its ...
Corporate Impact Report concluded better patient outcomes and substantial cost savings, thus accelerating Company's sales growth REDWOOD CITY, CA / ACCESSWIRE / August 30, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer h...
2023-08-15 21:13:04 ET Biotricity (BTCY) Q1 2024 Earnings Conference Call August 15, 2023 4:30 PM ET Company Participants Debra Chen – Investor Relations Waqaas Al-Siddiq – Founder and Chief Executive Officer John Ayanoglou – Chief Financial ...
2023-08-15 09:16:46 ET Biotricity press release ( NASDAQ: BTCY ): Q1 GAAP EPS of -$0.06. Revenue of $3.02M. Gross profit percentage was 63.5% for the three months ended June 30, 2023, as compared to 59.6% in the corresponding prior year quarter. For further detai...
REDWOOD CITY, CA / ACCESSWIRE / August 15, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced its financial results for the first quarter of fiscal...
REDWOOD CITY, CA / ACCESSWIRE / August 14, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, announced that it will host its First Quarter Fiscal Year 2024 Financ...
2023-08-11 08:26:18 ET Biotricity Inc ( NASDAQ: BTCY ) on Friday said company to report robust performance improvements in its operating metrics for the first fiscal quarter ended June 30, 2023. Record Q1-FY2024 recurring revenue growth. Significantly higher margins on tec...
Company to report robust performance improvements in its operating metrics Record Q1-FY2024 recurring revenue growth Significantly higher margins on technology fees compared to blended margins Strong control over sales and technology expenses through automation and AI REDWOOD...
2023-07-26 10:37:58 ET Gainers: ABVC BioPharma ( ABVC ) +50% . Benitec Biopharma ( BNTC ) +45% . Tilray Brands ( TLRY ) +23% . Teladoc Health ( TDOC ) +21% . Biodexa Pharmaceuticals ( BDRX ) +8% . Losers: Carmell Ther...
News, Short Squeeze, Breakout and More Instantly...
ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. (Nasdaq:BTCY) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 13, at 7 p.m. East...
REDWOOD CITY, CA / ACCESSWIRE / July 11, 2024 / Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced its accelerated timeline to achieving EBITDA positive. The company now expects to reach t...
REDWOOD CITY, CA / ACCESSWIRE / July 10, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced the launch of a new cardiac monitoring pilot program with a prominent hospital group enco...